KOSPI · 207940
Samsung Biologics
Market cap₩64.16T
PER38.61×
PBR7.73×
Foreign ownership12.74%
Avg. analyst target₩1,964,174
Pension summary
as of Oct 19streak3-day net buy
5D+₩178B
20D+₩123B
60D+₩233B
Foreign 20D-₩269B
Inst. 20D+₩210B
Pension daily net buy
-Cumulative net buying by investor
-선택 기간의 net buy Total · ₩100M
| Date | Close | Pension funds | Foreign | Institutions | Retail |
|---|---|---|---|---|---|
| 10/19 | 1,389,000 | +₩76.7B | -₩21.1B | +₩97.2B | -₩75.3B |
| 10/16 | 1,291,000 | +₩79.9B | -₩60.9B | +₩87.5B | -₩27.8B |
| 10/15 | 1,241,000 | +₩21.4B | -₩38.1B | +₩71.6B | -₩33.2B |
| 10/14 | 1,179,000 | -₩1.1B | -₩8.6B | -₩4.8B | +₩12.7B |
| 10/13 | 1,204,000 | +₩1.2B | -₩1.3B | +₩10.6B | -₩9.0B |
| 10/12 | 1,196,000 | +₩1.6B | -₩14.9B | +₩6.1B | +₩8.5B |
| 10/8 | 1,220,000 | -₩4.8B | -₩20.3B | -₩10.5B | +₩30.3B |
| 10/7 | 1,278,000 | -₩6.3B | -₩16.4B | -₩10.3B | +₩25.6B |
| 10/6 | 1,318,000 | -₩1.3B | -₩58.1B | +₩1.2B | +₩53.7B |
| 10/2 | 1,366,000 | -₩1.6B | -₩38.6B | -₩4.5B | +₩41.9B |
Discussion
Google-verified members · return since posting- Loading
Pension cost basis
Oct 19 Close · positions since 2024Pension cost basis1,361,201
Price vs. cost+2.0%
Holding value₩452B
Last 20 days+₩123B
Bought in the last 6 months only: avg. cost ₩1,373,035.
All pension cost data →세력 매집
last 60 trading days · Oct 19Foreign 60D−₩13.6B
Pension funds 60D+₩233B
세력 Avg. cost1,488,799
vs. cost Close-6.7%
Foreign+Pension funds Total 시총의 +0.3%, 60D price 폭 30%·Chg +3.3%. 세력 Avg. cost net buy한 날의 Avg 매수단가로 낸 est.치예요.
세력 매집 구간 All →Financial score
#52 of KOSPI 50070.5/100
- Value8
- Quality23
- Growth13
- Financials13.3
- Risk13.2
소외촉매 대기
증설·M&A 집행 확인과 파업 결과가 갈림길이라 Now 대기로 본다.
All stock scores →ETF
ETFs holding it in their top 10 · recent changes10/08 이후 큰 ETF 변화는 없어요
ETFs holding the most
- KODEX 삼성그룹5.3%
- KODEX KOSPI1.4%
- RISE KOSPI1.3%
- TIGER KOSPI1.3%
Recent filings
DART- Loading
Broker price targets
Recent 1YAvg1,933,333
High2,100,000
Low1,700,000
| Broker | Rating | Target | vs prior | Date |
|---|---|---|---|---|
| Kyobo Securities | Buy | 1,900,000 | Unch. | 26.10.08 |
| IBK Securities정OO | Buy | 2,000,000 | ▼4% | 26.10.07 |
| Daishin Securities | Buy | 2,000,000 | Unch. | 26.10.07 |
| SK Securities이OO | Buy | 2,000,000 | ▲54% | 26.10.06 |
| Yuanta Securities Korea하OO | Buy | 2,000,000 | ▼5% | 26.10.06 |
| Hana Securities | Buy | 1,950,000 | ▼5% | 26.10.06 |
| DS Securities | Buy | 1,850,000 | ▼5% | 26.08.31 |
| Kiwoom Securities | Buy | 2,000,000 | ▼5% | 26.08.31 |
| Mirae Asset Securities | Buy | 2,100,000 | ▼9% | 26.07.27 |
| iM Securities정OO | Buy | 1,900,000 | ▼14% | 26.07.24 |
| Shinhan Securities | Buy | 1,800,000 | Unch. | 26.07.24 |
| Eugene Investment & Securities | Buy | 1,700,000 | ▲31% | 25.10.29 |
Recent reports
- 3Q26 Preview: 수주 재개 기대, FX Down에도 컨센 부합Kyobo Securities · 10/08
- New 공장이 채운 Earnings, 수주가 더할 모멘텀IBK Securities · 10/07
- 단기 부담에도 컨센서스 부합 기대Daishin Securities · 10/07
- 3Q26 Pre: 파업과 FX 부담에도 컨센 부합SK Securities · 10/06
- FX Down에도 견조한 흐름Yuanta Securities Korea · 10/06
Latest report per broker in the past year · Source: Naver Securities Research, Hankyung Consensus · Analyst names masked
Same sector
Samsung Biologics summary
Samsung Biologics (207940). Pension funds: +₩123B over the last 20 trading days; 3-day net buying streak. Market cap ₩64.16T, PER 38.61×, PBR 7.73×. Avg. analyst target ₩1,964,174. Pension flows are based on Korea Exchange investor statistics, for reference only.